SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-010133
Filing Date
2024-03-15
Accepted
2024-03-15 17:00:59
Documents
122
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2133686
2 ex4-1.htm EX-4.1 45719
3 ex10-34.htm EX-10.34 288904
4 ex10-35.htm EX-10.35 280589
5 ex21-1.htm EX-21.1 2239
6 ex23-1.htm EX-23.1 3478
7 ex31-1.htm EX-31.1 12423
8 ex31-2.htm EX-31.2 11851
9 ex32-1.htm EX-32.1 8157
10 ex32-2.htm EX-32.2 7966
11 ex97.htm EX-97.DESCRIPTION 34141
12 ex97_001.jpg GRAPHIC 3134
  Complete submission text file 0001493152-24-010133.txt   10456120

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE bfri-20231231.xsd EX-101.SCH 85363
14 XBRL CALCULATION FILE bfri-20231231_cal.xml EX-101.CAL 106663
15 XBRL DEFINITION FILE bfri-20231231_def.xml EX-101.DEF 335601
16 XBRL LABEL FILE bfri-20231231_lab.xml EX-101.LAB 604267
17 XBRL PRESENTATION FILE bfri-20231231_pre.xml EX-101.PRE 487906
124 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1337683
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40943 | Film No.: 24755737
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)